8 results
A1C and eAG
~
*For Educational Purposes Only*

#Diabetes #T2D #DM2 #Table #PrimaryCare #Endocrinology #BloodGlucose #A1C
Diabetes #T2D #DM2 ... #Table #PrimaryCare
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
DPP-4 Inhibitors ... Action: Inhibits DPP ... Januvia) - Once/day tablet ... Onglyza) - Once/day tablet ... Pharmacology #Summary #DM2
AACE/ACE 2018 Glycemic Control Algorithm

#AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
Glycemic Control Algorithm ... Glycemic #Diabetes #DM2 ... Control #Medication #Algorithm ... Endocrinology #PrimaryCare
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Medications Summary Table ... events TZDs DPP ... #medications #table ... endocrinology #dm2
Algorithm and Differential Diagnosis of Tremor #Diagnosis #IM #PrimaryCare #Neuro #Tremor #Action #Rest #Differential #Algorithm #Comparison
Algorithm and Differential ... Diagnosis #IM #PrimaryCare ... #Differential #Algorithm ... #Comparison #Table
Type 2 Diabetes - Screening, Diagnosis and Management Algorithm
Lifestyle  Modifications (Diet and Exercise) -> Start
and Management Algorithm ... relative with DM2 ... Targets #Management #algorithm ... #DM2 #DMII #Classification ... #primarycare
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Sulfonylurea, TZD, DPP ... Diabetes #Mellitus #DM2 ... pharmacology #comparison #table
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
functional status - Able ... metabolic equivalent able ... Insulin dependent DM ... event, follow ACC algorithm ... Stable patients